✦ LIBER ✦

A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer

Book ID: 123427019
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 147 KB
Volume: 8
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(92)90048-O

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparative trial of LC9018 plus doxor

✍ Tomiya Masuno; Susumu Kishimoto; Takeshi Ogura; Takeshi Honma; Hisanobu Niitani; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

The efficacy and safety of intrapleural LC9018 (Yakult Co. Ltd., Tokyo, Japan) with or without doxorubicin (Adriamycin; Adria Laboratories, Columbus, OH) were evaluated in a randomized, controlled trial performed in 95 patients with malignant pleural effusions secondary to lung cancer. Seventy-six p

Etoposide combined with cyclophosphamide

Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: A randomized trial of the Bristol Lung Cancer Study Group

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 342 KB

Combined regimen of cisplatin, doxorubic

Combined regimen of cisplatin, doxorubicin, and α-2b interferon in the treatment of advanced malignant pleural mesothelioma : A Phase II multicenter trial of the Italian group on rare tumors (GITR) and the italian lung cancer task force (FONICAP)

✍ Héctor Soto Parra; Lucia Tixi; Fiorenza Latteri; Sergio Bretti; Marco Alloisio; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

53 POSTER A phase II, multicenter, rando

53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin®) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva®) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer

✍ R. Herbst; V. O'Neill; L. Fehrenbacher; C. Belani; P. Bonomi; L. Hart; O. Melnyk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB